Skip to content
Screener

Baxter International BAX Q1 2026 earnings

Reported April 30, 2026 · Before market open

Revenue$2.7BBeat by $85.5M
EPS$0.36Beat by $0.05
Revenue estimate$2.6B
EPS estimate$0.31

Next report

Oct 29, 2026 (in a month)
Revenue estimate$2.9B
EPS estimate$0.52

Financials

Q1 2026

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$8.67B-50.6%
Enterprise value$6.88B-55.6%
P/S0.8×-0.9×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Segments

By product

See full
Infusion Therapies & Technologies$981.0M-1.3%
Care & Connectivity Solutions$435.0M+1.9%
Drug Compounding$320.0M+30.1%
Advanced Surgery$304.0M+13.4%
Injectables & Anesthesia$301.0M-10.1%

By segment

See full
Medical Products & Therapies$1.3B+1.8%
Healthcare Systems & Technologies$705.0M+0.1%
Pharmaceuticals$621.0M+6.9%

By geography

See full
International$1.3B—

FAQ

When did Baxter International report Q1 2026 earnings?
Baxter International (BAX) reported Q1 2026 earnings on April 30, 2026 before market open.
What were Baxter International's Q1 2026 revenue and EPS?
Baxter International reported revenue of $2.7B and eps of $0.36 for Q1 2026.
Did Baxter International beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.6B by $85.5M. EPS beat the consensus estimate of $0.31 by $0.05.
How did Baxter International's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.9% from $2.6B a year earlier and eps declined 34.5% from $0.55.
Where can I find Baxter International's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-028582) and the 10-Q periodic report (0001628280-26-028962) directly on SEC EDGAR. The filing index links above go to sec.gov.